 we report on our fourth quarter and full year 2019 financial results and provide an update on our immuno-inflammatory pipeline. 
 we also provide an outlook for the fourth quarter and full year of 2020.    
 # 1_#1 _ # 1_#1 _ =    # 1 1.25 in.125 in.25 in 